Bittium will publish its Q1'26 results on April 29.
Yesterday, NanoRepro announced an increase in its direct equity stake in DKW alongside its FY25p rev...
* Net sales SEK 584m, +1% vs ABGSCe, -2% vs Factset cons.
Fiskars Q1 adjusted EBIT of EUR 25.0m came 26% above Modular Finance consensus expectations with in...
Redeye updates on Evolution Q1-results which were close to our expectations.
Net sales and adjusted EBITA were around 5% below market consensus (LSEG) in Q1.
Sales grew by 7% vs. Cons was expecting 11% y/y after strong ending of the last year (Q3/25: 14.
Atria reported Q1 adjusted EBIT of EUR 13.9m, 6% above LSEG Data & Analytics consensus.
Redeye provides an update following Senzime’s Q1 2026 report.
* We expect 35% organic growth in Q1e * Q1 mix likely to be somewhat favourable * FVR of SEK 30-45 r...
* Continued cautious market * '26e-'28e EBITA down 5-3% * Trading at 4.
* Entering 2026e in better shape * Early signs of an improving market * 7-5x EV/EBITA '26e-'28e, 16-...
* Q1 highlights long-term upside to margins * Adj. EBITA +0-2% on '26e-'28e; 8% CAGR '25-'28e * Near...
Redeye provides its estimates for Freemelt’s Q1 results and comments on some recent news.
Redeye comments on the recent phase Ia data from the Oxford-led BIO-002 study evaluating the RH5.
No longer a mere self-test company, NanoRepro has used the pandemic windfall from COVID tests and tr...
VNV saw its Q1 NAV decline 15.5% in USD terms q/q and reported an NAV per share of SEK 34 (-12.
We believe the market will appreciate BONESUPPORT's strong free cash flow and the upcoming triggers ...
* Adj. EBITA +16% y-o-y, 9% above Infront consensus * Beat driven by strong margins, while organic g...
Redeye comments on Evolution’s Q1-results which were close to our expectations, albeit with weaker-t...